TSHA logo

Taysha Gene Therapies (TSHA) Net income

annual net income:

-$89.30M+$22.27M(+19.96%)
December 31, 2024

Summary

  • As of today (June 22, 2025), TSHA annual net profit is -$89.30 million, with the most recent change of +$22.27 million (+19.96%) on December 31, 2024.
  • During the last 3 years, TSHA annual net income has risen by +$85.22 million (+48.83%).
  • TSHA annual net income is now -48.80% below its all-time high of -$60.01 million, reached on December 31, 2020.

Performance

TSHA Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

quarterly net income:

-$21.53M-$2.74M(-14.61%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TSHA quarterly net profit is -$21.53 million, with the most recent change of -$2.74 million (-14.61%) on March 31, 2025.
  • Over the past year, TSHA quarterly net income has increased by +$2.53 million (+10.52%).
  • TSHA quarterly net income is now -145.10% below its all-time high of $47.74 million, reached on December 31, 2023.

Performance

TSHA quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

TTM net income:

-$86.77M+$2.53M(+2.84%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TSHA TTM net profit is -$86.77 million, with the most recent change of +$2.53 million (+2.84%) on March 31, 2025.
  • Over the past year, TSHA TTM net income has increased by +$31.24 million (+26.47%).
  • TSHA TTM net income is now -7681.70% below its all-time high of -$1.11 million, reached on December 1, 2019.

Performance

TSHA TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TSHA Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.0%+10.5%+26.5%
3 y3 years+48.8%+57.2%+55.0%
5 y5 years--296.4%-1225.5%

TSHA Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+48.8%-145.1%+81.6%-281.0%+59.5%
5 y5-year-48.8%+48.8%-145.1%+81.6%-1225.5%+59.5%
alltimeall time-48.8%+48.8%-145.1%+81.6%-7681.7%+59.5%

TSHA Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$21.53M(+14.6%)
-$86.77M(-2.8%)
Dec 2024
-$89.30M(-20.0%)
-$18.79M(-26.4%)
-$89.30M(+292.1%)
Sep 2024
-
-$25.52M(+22.0%)
-$22.77M(-80.1%)
Jun 2024
-
-$20.93M(-13.0%)
-$114.33M(-3.1%)
Mar 2024
-
-$24.06M(-150.4%)
-$118.00M(+5.8%)
Dec 2023
-$111.57M(-32.8%)
$47.74M(-140.8%)
-$111.57M(-48.0%)
Sep 2023
-
-$117.09M(+376.0%)
-$214.38M(+73.1%)
Jun 2023
-
-$24.60M(+39.6%)
-$123.83M(-7.1%)
Mar 2023
-
-$17.62M(-68.0%)
-$133.32M(-19.7%)
Dec 2022
-$166.01M
-$55.08M(+107.6%)
-$166.01M(+2.9%)
Sep 2022
-
-$26.53M(-22.2%)
-$161.32M(-13.3%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$34.09M(-32.2%)
-$185.98M(-3.5%)
Mar 2022
-
-$50.32M(-0.1%)
-$192.82M(+10.5%)
Dec 2021
-$174.52M(+190.8%)
-$50.39M(-1.6%)
-$174.52M(+22.5%)
Sep 2021
-
-$51.19M(+25.1%)
-$142.46M(+34.0%)
Jun 2021
-
-$40.93M(+27.8%)
-$106.31M(+22.8%)
Mar 2021
-
-$32.02M(+74.8%)
-$86.60M(+44.3%)
Dec 2020
-$60.01M
-
-
Dec 2020
-
-$18.32M(+21.8%)
-$60.01M(+40.2%)
Sep 2020
-
-$15.04M(-29.1%)
-$42.81M(+54.2%)
Jun 2020
-
-$21.22M(+290.7%)
-$27.77M(+324.2%)
Mar 2020
-
-$5.43M(+387.1%)
-$6.55M(+487.1%)
Dec 2019
-
-$1.11M
-$1.11M

FAQ

  • What is Taysha Gene Therapies annual net profit?
  • What is the all time high annual net income for Taysha Gene Therapies?
  • What is Taysha Gene Therapies annual net income year-on-year change?
  • What is Taysha Gene Therapies quarterly net profit?
  • What is the all time high quarterly net income for Taysha Gene Therapies?
  • What is Taysha Gene Therapies quarterly net income year-on-year change?
  • What is Taysha Gene Therapies TTM net profit?
  • What is the all time high TTM net income for Taysha Gene Therapies?
  • What is Taysha Gene Therapies TTM net income year-on-year change?

What is Taysha Gene Therapies annual net profit?

The current annual net income of TSHA is -$89.30M

What is the all time high annual net income for Taysha Gene Therapies?

Taysha Gene Therapies all-time high annual net profit is -$60.01M

What is Taysha Gene Therapies annual net income year-on-year change?

Over the past year, TSHA annual net profit has changed by +$22.27M (+19.96%)

What is Taysha Gene Therapies quarterly net profit?

The current quarterly net income of TSHA is -$21.53M

What is the all time high quarterly net income for Taysha Gene Therapies?

Taysha Gene Therapies all-time high quarterly net profit is $47.74M

What is Taysha Gene Therapies quarterly net income year-on-year change?

Over the past year, TSHA quarterly net profit has changed by +$2.53M (+10.52%)

What is Taysha Gene Therapies TTM net profit?

The current TTM net income of TSHA is -$86.77M

What is the all time high TTM net income for Taysha Gene Therapies?

Taysha Gene Therapies all-time high TTM net profit is -$1.11M

What is Taysha Gene Therapies TTM net income year-on-year change?

Over the past year, TSHA TTM net profit has changed by +$31.24M (+26.47%)
On this page